NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET FORECAST 2023-2032

The North America kidney stone retrieval devices market growth analysis encompasses the assessment of the United States and Canada. The kidney stone retrieval devices market in the United States has experienced significant growth over recent years, propelled by the escalating prevalence of kidney stones and urinary system stone disease (USSD). Over the years, the incidence of kidney stones in the country has surged, spiking from 3.8% in the late 1970s to 8.8% in the late 2000s, with a further increase to 10% during 2013-2014.

Several factors contribute to the escalating incidence of kidney stones, including the presence of comorbidities such as high blood pressure, diabetes, etc. These ailments are becoming highly pervasive in the United States, amplifying the susceptibility to kidney stone formation. However, the impact of kidney stones extends beyond individual patients, casting a substantial burden on the healthcare system. Besides, treating kidney stones entails considerable costs and resource consumption, as well. 

Furthermore, the substantial uptick in health expenditure within the United States has served as a catalyst for the expansion of the market. For instance, in 2021, health spending in the nation witnessed a 2.7% surge, culminating at $4.3 trillion and translating to $12,914 per capita. This heightened commitment to healthcare investment has paved the way for avenues of innovation and progression in medical technology, subsequently driving the North America kidney stone retrieval devices market growth.

The North America kidney stone retrieval devices market is segmented into product type, treatment, and end-user. The product type segment includes lithotripters, stone removal baskets, ureteral stents, and ureterorenoscopes. Lithotripters stand as non-invasive, non-surgical marvels that harness electromagnetic shock waves transmitted through a water bath to fragment kidney and gallbladder stones.

Constituting essential components like an examination and treatment table, an imaging system, a shock-wave generator, and a control console, the device splinters kidney stones into more manageable fragments for effortless elimination through urine. Moreover, it finds utility in extracorporeal shock wave lithotripsy (ESWL) and intracorporeal ureteroscopy procedures. With a classification as a class II device by the US FDA, lithotripters enable the efficient removal of stones within a concise 30-minute timeframe.

Some of the leading companies operating in the North America kidney stone retrieval devices market include Boston Scientific Corporation, Becton, Dickinson and Company, etc.

Boston Scientific Corp, headquartered in the United States, is a medical technology company that manufactures, commercializes, and develops devices for a range of interventional medical specialties. The company provides products across the areas of electrophysiology, gastrointestinal surgery, gastroenterology, female pelvic medicine, interventional cardiology, gynecology, neurological surgery, orthopedic surgery, interventional radiology, pain medicine, urology and vascular surgery, and pulmonology. The company caters to clinics, outpatient facilities, hospitals, and medical offices across the globe.